Please login to the form below
infections
This page shows the latest infections news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
Sanofi taps Evotec for new anti-infectives drive
aim of developing new drugs for bacterial, viral, fungal and parasitic infections.
-
Gilead says switching studies back new HIV therapy Biktarvy
The latest data was reported at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.
-
Novo launches $165m antimicrobial resistance initiative
According to Novo, more than 700, 000 people die each year from infections resistant to most or all antibiotics, and by 2050 antimicrobial resistance is projected to end more lives than
-
J&J takes option on Theravance’s JAK drug in $1bn deal
It is designed to exert its activity primarily within the GI tract with limited systemic uptake - potentially reducing side effects associated with drugs in the class such as infections, liver damage,
-
Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought
Zavicefta is already approved in Europe for HABP/VABP. One of the key roles for the new product is in the treatment of infections with carbapenem-resistant Enterobacteriaceae (CRE). ... Gram-negative pathogens are some of the most pressing antibiotic
More from news
Approximately 11 fully matching, plus 874 partially matching documents found.
Latest Intelligence
-
The threat of antimicrobial resistance
This global research, looking at 13, 000 patients across 66 countries, found that over 12% of those undergoing procedures developed a post-operative surgical site infection (SSI). ... After all, so many of today’s life-saving healthcare advances, from
-
Waking the sleeping giant
learning anatomy, practising operations or even teaching infection control.
-
Significant figures
NTM is a rare progressive, destructive infection that’s normally found in addition to pulmonary diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis or bronchiectasis. ... Its novel therapy is an inhaled formulation of
-
Healthcare Glossary
Asymptomatic. Showing no signs of a disease or infection.
-
Not dying of ignorance - 30 years on
However, rates of infection in the gay community dropped following the campaign.
More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.
Latest appointments
-
Nabriva Therapeutics appoints chief medical officer
Nabriva Therapeutics, a biopharma focused on treating bacterial infections, has appointed a new chief medical officer in the form of Jennifer Schranz.
-
Nabriva Therapeutics appoints new chief commercial officer
Bacterial infections focussed Nabriva Therapeutics has appointed Francesco Maria Lavino as its chief commercial officer ahead of the group’s phase III clinical trial for lefamulin - a potential new treatment for ... I am looking forward to working with
-
Germany's Ventaleon names biotech entrepeneur CEO
patients suffering from serious infections such as influenza to get better, faster.
-
Destiny Pharma appoints new CEO
surgical infections from all strains of Staphylococcus aureus, which we believe is a blockbuster opportunity.”.
-
Dr Engelbert Tjeenk Willink joins Allecra Therapeutics
Allecra’s technology provides an important new treatment for hospital clinicians who are grappling with these types of infection.”. ... Hooftman’s new role will see him focus on combating multi drug-resistant Gram-negative bacterial infections.
More from appointments
Approximately 1 fully matching, plus 20 partially matching documents found.
Latest from PMHub
-
Our nursing heroes
The patient had a persistent chest infection and her GP had prescribed more antibiotics and sent her for an X-ray. ... Sadly it wasn’ t just a chest infection, and without Aine’ s intervention it could have taken a long time for it to come to our
-
New analysis shows emergency hospital admissions for people with Multiple Sclerosis continue to rise
For example, the report found that urinary tract infections accounted for 14 percent of emergency admissions for MS in 2015/16 and they cost £2, 639 per patient; while respiratory issues ... Preventative care strategies for people with MS must be
-
How can pharma engage with NHS Vanguards?
Pharma could also identify new issues. For example, NHiS identified a huge number of emergency hospital admissions for urinary tract infections in several NHS Clinical Networks which led to a review
-
How will capitated budgets affect NHS spending?
Also, it’ s often safer for patients to receive treatment at home to avoid iatrogenic diseases, for example, infections in immune-suppressed patients.
-
How can pharma help the NHS capitalise on its data?
Similarly, they do not know where improvements and cost-savings could be made by, for example, treating recurrent infections in patients suffering from diseases such as multiple sclerosis at primary care
More from PMHub
Approximately 1 fully matching, plus 21 partially matching documents found.
Featured jobs
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
- Account Manager – Med Comms – London
-
Salary TBC
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Medical Writer, e-learning/ training, London
-
Excellent Salary
- Senior Account Manager / Account Director
-
Great salary and bebefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
-
Senior Medical Writer
-
Great salary and bebefits
- Project Manager, Medical Communications, London
-
Excellent Salary
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
Subscribe to our email news alerts
No results were found
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
